Maine LD1053 ensures rebates from prescription drug manufacturers are passed on to patients at pharmacies.
Maine LD1053 amends the law to require that compensation from pharmaceutical manufacturers be directly remitted to the covered person at the point of sale to reduce out-of-pocket costs. It mandates annual reporting by carriers and pharmacy benefits managers to the Superintendent of Insurance, who can impose penalties for noncompliance. The information provided remains confidential.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.